Skip to content

Reduced lung-cancer mortality with low-dose CT

Published: October 18, 2026Updated: October 18, 2026

National Lung Screening Trial Research Team, Aberle DR, Berg CD

New England Journal of Medicine · 2011

This randomized controlled trial evaluates the intervention under study in relation to the primary clinical outcome. Includes 53,454 participants. Evidence level: Ia.

Quick summary

循证研究:低剂量CT肺癌筛查研究

Medically reviewed by WellAlly Editorial TeamLast reviewed October 18, 2026Editorial policy

Key facts at a glance

DOI
10.1056/NEJMoa1102873
PMID
21714641
Journal
New England Journal of Medicine
Year
2011
Study type
rct
Evidence level
Ia
Sample size
53454
Intervention
低剂量 CT vs 胸片年度筛查
Primary outcome
肺癌死亡率
Open access
false

Study Overview

This randomized controlled trial enrolled 53,454 participants and examined the primary clinical outcome.

Key Findings

Results regarding the primary clinical outcome are presented.

Clinical Conclusions

See original publication for detailed findings. Evidence level: Ia.

Abstract

"This randomized controlled trial enrolled 53,454 participants, investigating the effects of 低剂量 CT vs 胸片年度筛查 on 肺癌死亡率.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed October 18, 2026. · Read our editorial policy

More rct studies

View all